1374655-69-2 Usage
Uses
Used in Pharmaceutical Industry:
3-Bromo-4-ethyl-5-fluoropyridine is used as a key intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of novel drug molecules with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 3-Bromo-4-ethyl-5-fluoropyridine is utilized as a building block for the creation of new agrochemicals, enhancing crop protection and yield through the development of innovative products.
Used in Fine Chemicals Production:
3-Bromo-4-ethyl-5-fluoropyridine is employed as an intermediate in the production of fine chemicals, contributing to the synthesis of specialty compounds used across various industries.
Used in Dyes and Pigments Industry:
3-BroMo-4-ethyl-5-fluoropyridine is also used as a precursor in the synthesis of dyes and pigments, providing a foundation for the creation of vibrant and stable colorants for various applications, including textiles, plastics, and printing inks.
Check Digit Verification of cas no
The CAS Registry Mumber 1374655-69-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,7,4,6,5 and 5 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1374655-69:
(9*1)+(8*3)+(7*7)+(6*4)+(5*6)+(4*5)+(3*5)+(2*6)+(1*9)=192
192 % 10 = 2
So 1374655-69-2 is a valid CAS Registry Number.
1374655-69-2Relevant academic research and scientific papers
PYRAZOLOPYRIDYL COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS
-
Page/Page column 37, (2013/04/10)
This invention relates to pyrazolopyridyl compounds of the structural formula: [Formula should be inserted here] or their pharmaceutically acceptable salts, wherein the variable are defined herein. The inventive compounds selectively inhibit aldosterone s
ALDOSTERONE SYNTHASE INHIBITORS
-
Page/Page column 49, (2012/11/13)
This invention relates to tricyclic triazole analogues of the formula I or their pharmaceutically acceptable salts, wherein the variable are defined herein. The inventive compounds selectively inhibit aldosterone synthetase. This invention also provides for pharmaceutical compositions comprising the compounds of Formula I or their salts as well as to methods for the treatment, amelioration or prevention of conditions that could be treated by inhibiting aldosterone synthetase.
